Compound ID | 413
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Use against CAP |
| Description: | Oral |
| Institute where first reported: | LG Life Sciences, South Korea |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9851428 |
| Citation: | https://journals.asm.org/doi/10.1128/aac.44.12.3272-3277.2000 |